EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments

Go back to EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments
(NASDAQ: EYPT) Delayed: 4.50 -0.06 (1.32%)
Previous Close $4.56    52 Week High
Open $4.50    52 Week Low
Day High $4.55    P/E N/A 
Day Low $4.45    EPS
Volume 357,292